The International Collaborative Study of Maternal Phenylketonuria Status Report 1998

R. Koch, E. Friedman, C. Azen, W. Hanley, H. Levy, R. Matalon, B. Rouse, F. Trefz, S. Waisbren, K. Michals-Matalon, P. Acosta, F. Güttler, K. Ullrich, L. Platt, F. De La Cruz

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The Maternal PKU Study began in 1984 and during the intervening years, 572 pregnancies in women with hyperphenylalaninemia (HPA) and 99 controls and their outcomes have been evaluated. Among Women with HPA who delivered a live infant, only 15.9% were treated and in metabolic control preconceptionally; however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptionally treated pregnancies with well-controlled phenylalanine-restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring; however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/L. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

Original languageEnglish (US)
Pages (from-to)117-121
Number of pages5
JournalMental Retardation and Developmental Disabilities Research Reviews
Issue number2
StatePublished - 1999


  • Congenital heart disease
  • Maternal Phenylketonuria Collaborative Study
  • Phenylalanine
  • Phenylketonuria
  • Wechsler Adult Intelligence Quotient- Revised (WAIS-R)
  • Wechsler Intelligence Quotient-Revised (WISC-R)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neuropsychology and Physiological Psychology
  • Genetics(clinical)


Dive into the research topics of 'The International Collaborative Study of Maternal Phenylketonuria Status Report 1998'. Together they form a unique fingerprint.

Cite this